Skip to main content
MannKind Corporation (MNKD)
NASDAQ: MNKD · Real-Time Price · USD
6.85
+0.55 (8.73%)
Dec 20, 2024, 4:00 PM EST - Market closed

MannKind Revenue

MannKind had revenue of $70.08M in the quarter ending September 30, 2024, with 36.73% growth. This brings the company's revenue in the last twelve months to $267.20M, up 51.35% year-over-year. In the year 2023, MannKind had annual revenue of $198.96M with 99.42% growth.

Revenue (ttm)
$267.20M
Revenue Growth
+51.35%
P/S Ratio
6.97
Revenue / Employee
$645,411
Employees
414
Market Cap
1.89B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023198.96M99.19M99.42%
Dec 31, 202299.77M24.33M32.25%
Dec 31, 202175.44M10.30M15.81%
Dec 31, 202065.14M2.11M3.34%
Dec 31, 201963.04M35.18M126.28%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Astrana Health 1.72B
National HealthCare 1.22B
GoodRx Holdings 790.39M
Certara 372.80M
Galapagos NV 290.09M
Recursion Pharmaceuticals 65.18M
ImmunityBio 7.33M
Revenue Rankings

MNKD News

More News